S-Allyl-L-cysteine (SAC), the most abundant organosulfur compound derived from garlic, has multifunctional biological activities that occur via different mechanisms. A sensitive, rapid and simple LC -ESI -MS/MS method using a mixed-mode reversed-phase and cation-exchange column containing C18 silica particles and sulfonic acid cation-exchange particles has been developed and validated for the analysis of SAC in rat plasma. The mobile phase was optimized at 2 mM ammonium acetate buffer ( pH 5 3.5) and acetonitrile (75:25, v/v). The assay utilized 0.6% acetic acid in methanol to achieve simple and rapid deproteinization. Quantification was conducted using multiple reaction monitoring (MRM) of the transitions of m/z 162.0 ! 145.0 for SAC. The standard curve for SAC was linear (r 2 ! 0.999) over a range from 5 to 2,500 ng/mL. The intra-and interday precision (relative standard deviation) of the method was not >6.0% at three quality control levels. The limit of quantification (LOQ) was 5.0 ng/mL. After being fully validated, the method was successfully applied to the pharmacokinetic monitoring of SAC in rat plasma.
Introduction
Garlic (Allium sativum) is one of the oldest medicinal plants. The characteristic odor of garlic is attributed to its sulfurcontaining compounds, including alliin, allicin, diallylsulfide, diallyldisulfide, diallyltrisulfide and cycloalliin. Numerous sulfurcontaining compounds have been derived from garlic, and their biological activities have been investigated (1) . Recently, S-allyl-L-cysteine (SAC), a sulfur-containing amino acid derived from garlic, has been reported to have antioxidant activity (2, 3) , anti-cancer promoting activity (4, 5) , anti-hepatopathic activity (6) and neurotrophic activity (7, 8) . SAC is known to be a metabolite of allyl aldehydes and allyl esters and is easily absorbed in the gastrointestinal tract and distributed in the plasma, liver and kidneys (9) . At present, SAC is the only compliance marker used in clinical studies involving garlic consumption (10) . Therefore, the bioavailability of SAC plays an important role in determining the biological response to aqueous garlic preparations, including aged garlic extract and black garlic (11, 12) .
However, SAC analysis is challenging due to its high polarity and small molecular size, which lead to poor retention of SAC on reversed-phase liquid chromatographic columns, such as C18 and C8 (13) . Therefore, derivatization and ion-pair reagents are normally used to improve the retention of SAC on C18 and C8 columns. Earlier publications have described high-performance liquid chromatography equipped with ultraviolet detection (HPLC-UV) and mass spectrometry (MS) for the quantification of SAC in biological samples (9, 13) . However, these methods require additional time-consuming procedures during the derivatization step.
Recently, new mixed-mode reversed-phase and cationexchange columns (CAPCELL PAK CR) have been developed in which C18 silica particles and strong cation-exchange particles are mixed inside (14) . Mixed-mode reversed-phase and cation-exchange HPLC combines the advantages of reversedphase chromatography and ion-exchange chromatography, which is suitable for the separation of mixtures of polar and ionizable compounds.
Until now, no analytical methods could be used to quantify SAC without precolumn derivatization in rat plasma. In the present study, we chose the LC -ESI -MS/MS method on a mixedmode column for use in pharmacokinetic studies in rat plasma based on its superior sensitivity, convenience and efficiency in detecting SAC. The method was validated for selectivity, sensitivity, recovery, matrix effect, linearity, accuracy, precision and stability in accordance with FDA guidelines.
Experimental
Chemicals and reagents SAC was purchased from LKT Lab (Saint Paul, MN, USA). Acetonitrile (ACN) was purchased from Fisher Scientific (Fair Lawn, NJ, USA). Methanol (MeOH) was purchased from J.T. Baker (Center valley, PA, USA). Water was purified with a Milli-Q system (Millipore, Bedford, MA, USA). All chemicals used were the highest quality available.
Preparation of the standard and quality control samples
The standard stock solution of SAC was prepared in 10% MeOH at a concentration of 1 mg/mL and dissolved using a vortex mixer for 5 min. Due to the low solubility of the compound, sonication for 5 min was necessary.
Calibration curves were obtained by spiking 100 mL of the standard solution diluted with 0.6% acetic acid (AA) in MeOH into 100 mL of blank rat plasma and mixing using a vortex mixer followed by the addition of 800 mL of ice-cold 0.6% AA in MeOH. The standard plasma samples were then mixed for a few seconds and centrifuged at 3,000 rpm for 10 min at 48C. The final concentrations in the standard plasma samples were 5, 10, 25, 50, 100, 250, 500, 1,000 and 2,500 ng/mL of SAC. Three levels of quality control (QC) samples at 5, 250 and 2,500 ng/mL were prepared in plasma for the determination of inter-and intra-assay precision and accuracy. The aliquots of the standards and QC samples were stored frozen at 2208C prior to analysis.
Sample preparation
Rat plasma samples were stored frozen at 2808C prior to analysis. At first, the plasma samples were thawed, equilibrated to room temperature and vortex mixed. Then, 900 mL of ice-cold 0.6% AA in MeOH and 100 mL of the rat plasma samples were placed in Eppendorf tubes (1.5 mL). The samples were mixed for 2 min using a vortex mixer and centrifuged at 3,000 rpm for 10 min at 48C. The supernatants were then transferred to autosampler vials and 5 mL of each sample was injected into the HPLC -MS/MS system for analysis. The optimization of precipitation was obtained by the addition of organic solvent (10-fold diluted to 0.6% AA in MeOH) to the rat plasma samples.
LC -ESI-MS/MS instruments
Analyses were performed on an Agilent 1200 pump LC system (Agilent Technologies, Santa Clara, CA, USA) coupled to a 4000 QTRAP mass spectrometer instrument equipped with a TurboIonSpray ionization source (Applied Biosystems, AB SCIEX, Foster City, CA, USA).
SAC separation was carried out using a CAPCELL PAK CR 1:4 column (100 Â 2.0 mm i.d., 3 mm particle size) from Shiseido (Tokyo, Japan). The column was operated at ambient temperature. The flow rate of the mobile phase was 0.15 mL/min. For all of the separations, eluent A of the mobile phase was 2 mM ammonium acetate buffer ( pH ¼ 3.5) and eluent B was 0.1% formic acid in ACN. The injection volume was 5 mL. Positive ionization was performed with the following settings: ion spray voltage, 5,000 V; curtain gas 20 AU; GS1 and GS2, 50 and 30 psi, respectively; probe temperature, 5508C.
Quantification was performed using multiple reaction monitoring (MRM) of the transitions of m/z 162.0 ! 145.0 for SAC. The optimal declustering potential, entrance potential, collision energy (CE) and collision-cell exit potential for SAC were 40, 10, 15 and 15 V, respectively.
Method validation
The developed method was validated according to the Guidelines for Bioanalytical Method Validation of the Food and Drug Administration (FDA) (15) . The analytical method for SAC was validated with regard to selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), precision and accuracy.
Selectivity and linearity
Selectivity was evaluated by analyzing blank rat plasma samples that had been obtained from six different rats. Linearity was assessed by constructing calibration standards from 5 to 2,500 ng/mL. The LOD was based on the standard deviation of the y-intercept of the regression analysis (a) and the slope (S) using the equation LOD ¼ 3.3a/S. The LOQ was calculated using the equation LOQ ¼ 10a/S.
Precision and accuracy
The precision and accuracy were determined by analyzing three replicates of spiked samples at each level. Three independent analyses were conducted each day at the three concentration levels listed above to determine repeatability (n ¼ 5, intraday precision). These analyses were repeated for three consecutive days to determine the reproducibility of the method (n ¼ 9, interday precision) using the same concentration levels, both of which were assessed as a function of the variation relative standard deviation (RSD). The accuracy of the method was evaluated by quantifying the recovery of the standards from the samples.
Recovery, matrix effect and stability
The extraction recovery of SAC was evaluated by comparing the peak areas of QC samples with those of postextraction blank plasma samples that had been spiked with equivalent concentrations of analyte. The matrix effect was assessed by comparing the peak areas of spike-after-extraction samples with standard solutions at three QC levels.
The stability of SAC in rat plasma was investigated following a variety of storage conditions. The short-term stability (at room temperature for 8 h), freeze and thaw stability (2808C to room temperature) and postpreparative stability (kept in the autosampler at 48C for 24 h) were assessed.
Application to pharmacokinetic studies
This validated LC-MS/MS method was applied to a pharmacokinetic study in healthy male Sprague -Dawley rats (weight range 180 -200 g) that had been fasted overnight ( 18 h) following the approval of the ethical committee. During fasting, the animals had free access to water. The rats were randomly grouped into two major groups: intravenous (i.v.) and oral ( p.o.) administration, with three subdivisions of three dosages in each major group. The i.v. dosages of SAC were 12.5 and 25 mg/kg and were prepared in isotonic saline. The p.o. dosages were also 1, 12.5 and 25 mg/kg and were made by dissolving SAC powder in deionized water.
Blood samples were collected in heparinized tubes at 0, 5, 15 and 30 min and 1, 2, 4 and 6 h after administration. The rat plasma samples were centrifuged at 3,000 rpm for 10 min, collected and frozen at 2808C prior to analysis.
The pharmacokinetic parameters of SAC were estimated using the non-compartmental method with BA Calc 2007 software that was provided by the Korean FDA (KFDA, Seoul, Korea). The maximum plasma concentration (C max ) and the time that it took to reach the maximum plasma concentration (T max ) were the observed values. The area under the plasma concentrationtime curve (AUC) was calculated using the linear trapezoidal rule. The elimination rate constant (k e ) was determined by linear regression analysis of the log -linear portion of the plasma concentration -time curve. The AUC from 0 to infinity (AUC inf ) was calculated as follows: AUC inf ¼ AUC t þ C t /k e (C t is the last plasma concentration measured). The half-life (T 1/2 ) was calculated as: ln 2/k e .
Results

Method development
The MS/MS parameters were optimized by varying the CE values in the ion spray mode by direct continuous pump infusion of the standard solution of SAC (Table I ). According to this process, a much stronger signal was investigated in the positive mode than in the negative mode.
The SAC analysis was performed in the positive mode. The detection of the analyte was conducted using the MRM mode. The [MþH] þ ion was used at m/z 162 as a protonated molecular ion. The product ion of m/z 162 showed a high abundance fragment ion at m/z 145 as the target ion. The fragmentation patterns are shown in Figure 1 .
To SAC analysis, a mixed-mode reversed-phase and cation-exchange columns (CAPCELL PAK CR ¼ 1:4) have been developed. To optimize the mobile phase, the 2 mM ammonium acetate buffer ( pH ¼ 3.5) was chosen, which lead to a better peak shape and signal intensity.
The optimal protein precipitation was determined to have occurred at a concentration of 0.6% AA in MeOH.
Method validation
The proposed analytical method for SAC in rat plasma was validated with regard to specificity, linearity, sensitivity, precision and accuracy.
Specificity
The specificity of the method was evaluated by analyzing individual blank plasma samples.
Representative chromatograms of a standard solution of SAC (10 ng/mL) (A), a rat blank plasma (B) and a rat plasma sample that was obtained from a rat after oral administration (C) are shown in Figure 2 . No potential interfering peaks from endogenous matrix components were observed at the retention time of SAC.
Linearity and sensitivity
The calibration curve for SAC was linear over a concentration range from 5 to 2,500 ng/mL (Table I ). The mean value of the regression equation was y ¼ (3,662.6 + 218.6)x þ (44,318.9 + 13,886.8) (n ¼ 5), with a coefficient of determination of r 2 . 0.999, where y is the peak area of SAC and x is the plasma concentration of SAC. According to the equation of LOQ (10a/S), the value was 4.4 ng/mL. However, we set the LOQ as 5 ng/mL which is near 4.4 ng/mL for the convenience and accuracy of the dilution. This value was sufficient for the determination of SAC in rat plasma as it met the validation criteria. With the present LOQ, SAC could be detected in rat plasma until 6 h after oral dosing, which was sensitive enough to investigate the pharmacokinetics of SAC in rats.
Precision and accuracy
The intra-and interday precision and accuracy were calculated by analyzing three concentration levels of QC samples, the results of which are shown in Table II . Both the intra-and interday precision and accuracy were ,6.0% for SAC. The results demonstrated that the precision and accuracy of the method were within the acceptable ranges and the developed method was precise and reproducible.
Extraction recovery and matrix effect
The QC samples were diluted 10-fold with blank plasma and 0.6% AA in MeOH solvent. The extraction recoveries of SAC ranged from 93.8 to 100.3% at concentrations of 5, 250 and 2,500 ng/ mL. The matrix effect values for SAC were 92.4, 91.0 and 89.2% at the three concentrations levels of QC samples. These results indicate that the developed analytical method is reliable and is subject to minimal matrix effect.
Stability
The QC level samples and stock solution stability were also determined. The results of the stability tests are presented in Table III . SAC was demonstrated to be stable in rat plasma that had been stored at room temperature for 24 h, during three freeze -thaw cycles, and in the autosampler after being handled for 24 h. All of the RSD values were ,7.2% for SAC, demonstrating that SAC was stable during sample storage. Also, the stock solution of SAC in 10% MeOH was stable at a nominal temperature of 48C for at least 30 days. Figure 3 . Following oral administration, SAC was rapidly absorbed and the maximum plasma concentration (C max ) appeared at 0.5 + 0.1, 10.5 + 2.0 and 15.2 + 2.4 mg/mL following 1, 12.5 and 25 mg/kg administration, respectively. The absolute bioavailability of SAC was calculated to be 80.0 and 96.1% at dosages of 12.5 and 25 mg/kg, respectively (Table IV) . Our results are in accordance with the results of a previous study (9) .
Discussion
SAC was not retained on a reversed-phase column because it is a small molecule with high polarity. To retain enough SAC, a mixed reversed-phase and cation-exchange analytical column, which contained both C18 bonded silica particles and sulfonic acid cation-exchange particles, was adopted. To optimize the mobile phase, ammonium acetate buffer concentrations of 2, 5, 10 and 15 mM at a range of pH (from 3 to 4.5) were investigated. As a result, 2 mM ammonium acetate buffer ( pH ¼ 3.5) was chosen, which lead to a better peak shape and signal intensity.
The SAC analysis was performed in the positive mode. The [MþH] þ ion was used at m/z 162 as a protonated molecular ion. The ion transition of m/z 162 ! 145 as the quantification ion and m/z 162!73 as the identification ion were chosen for the MRM of SAC.
Due to possible concentrations of interfering substances in biological samples, it is necessary to optimize sample extraction with high recovery prior to HPLC analysis (16) . Krijt et al. (17) have mentioned that protein precipitation is the simplest way to prepare biological samples for LC -MS/MS analysis. This extraction method is cost effective, provides a shorter sample preparation procedure and minimizes the sample and standard volumes. To select a protein precipitation solvent, solvents including MeOH, ACN and AA were tested by varying the portion of organic solvents from 0.4, 0.5 and 0.6 to 1% (18, 19) . The polarity of the extraction solvent may also have an effect on the extraction efficiency of polar compounds that are present in food materials (20) . By increasing the organic solvent, which results in the removal of some of the interfering compounds, the sensitivity of the mass spectrometer may be improved (21) . Therefore, optimal protein precipitation was determined to have occurred at a concentration of 0.6% AA in MeOH (dilution 1:10) because the extraction recovery was within the acceptable ranges and the peak shape was good. This sample preparation method without derivatization is so simple that it may prove to be a quick and effective procedure.
Conclusions
The presented method for SAC analysis using LC -ESI -MS/MS with a mixed reversed-phase and cation-exchange analytical column has been developed, optimized and validated. The method offered a simple one-step protein precipitation procedure, a shorter running time of no more than 3 min and greater sensitivity (5.0 ng/mL). The present method showed high sample throughput and has been successfully applied to the pharmacokinetic analysis of SAC in rat plasma. 
